Together, these two pathways produce a broader metabolic response than GLP-1 activation alone, which is why tirzepatide has shown more pronounced effects on body weight and blood sugar control in clinical research compared to GLP-1-only medications
There is no one-size-fits-all answer because everyone's metabolic rate and daily stressors are different
Smith GI, Julliand S, Reeds DN, Sinacore DR, Klein S, Mittendorfer B
Stable gastric pentadecapeptide BPC 157 and wound healing Summary: This review discussed BPC-157's potential in wound healing, including its ability to resolve vessel constriction, primary platelet plug, and fibrin mesh, and its effectiveness in counteracting bleeding disorders and thrombosis
Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) New England Journal of Medicine 68-week trial of 1,961 adults showed semaglutide 2.4 mg weekly achieved 14.9% mean body weight loss versus 2.4% with placebo, establishing landmark weight management efficacy
[PMC free article: PMC4669071] [PubMed: 25614320] 63